Ftse Mib
38.779,67
0,68%
DAX
23.419,48
1,30%
S&P 500
5.738,52
-1,78%
NASDAQ
18.069,26
-2,61%
Bitcoin
87.162,28
-3,08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Entera Bio Ltd (ENTX) Entera Bio Ltd (ENTX) Notizie

Entera Bio Ltd

ENTX
1,87
-0,07 (-3,61%)
07 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202514:30GLOBEEntera Bio to Participate in Upcoming Events
19/2/202514:00GLOBEEFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND..
27/1/202514:00GLOBEEntera Bio to Present at the Oppenheimer 35th Annual..
17/1/202522:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202522:06EDGAR2Form 8-K - Current report
10/1/202522:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
08/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202422:05EDGAR2Form 8-K - Current report
08/11/202422:05GLOBEEntera Bio Reports Q3 2024 Financial Results and Provides..
04/10/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202414:30GLOBEEntera Bio and OPKO Health Provide Update on PK/PD Results..
29/8/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202414:00GLOBEEntera Bio to Participate in Upcoming Investor and..
20/8/202412:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
09/8/202422:12EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202422:05EDGAR2Form 8-K - Current report
09/8/202422:05GLOBEEntera Bio Reports Q2 2024 Financial Results and Provides..
02/8/202422:31EDGAR2Form 8-K - Current report
02/8/202422:31EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
02/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202414:30GLOBEEntera’s EB613, the First Once Daily PTH(1-34) Tablet..
07/6/202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/6/202414:00GLOBEEntera Bio Reports Phase 1 Clinical Data of First-in-Class,..
29/5/202422:08EDGAR2Form PRE 14A - Other preliminary proxy statements
15/5/202414:00GLOBEEntera Bio Appoints Dr. Rachel B Wagman as Key Clinical..
13/5/202413:00GLOBEEntera Bio to Present Phase 1 Data from First-in-Class,..
10/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:10EDGAR2Form 8-K - Current report
10/5/202422:10GLOBEEntera Bio Reports Q1 2024 Financial Results and Provides..
08/4/202414:30GLOBEEntera Bio Announces Publication of Oral PTH(1-34) Peptide..
26/3/202413:30GLOBEEntera Bio Announces Key Regulatory Milestone for Oral..
20/3/202413:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
08/3/202422:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202422:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202422:10EDGAR2Form 8-K - Current report
08/3/202422:05GLOBEEntera Bio Announces Full Year 2023 Financial Results and..
Apertura: 2,0016 Min: 1,82 Max: 2,0016
Chiusura: 1,94

La tua Cronologia

NASDAQ
ENTX
Entera Bio
GATE
SINUSDT
SinCity Token
NYSE
HIMS
Hims and Hers Health
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci